pentoxifylline

Generic: pentoxifylline

Labeler: apotex corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pentoxifylline
Generic Name pentoxifylline
Labeler apotex corp.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

pentoxifylline 400 mg/1

Manufacturer
Apotex Corp.

Identifiers & Regulatory

Product NDC 60505-0033
Product ID 60505-0033_e67bdb49-8c37-8b4f-c982-67d024d3f2aa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075191
Listing Expiration 2026-12-31
Marketing Start 1999-06-10

Pharmacologic Class

Established (EPC)
blood viscosity reducer [epc]
Physiologic Effect
hematologic activity alteration [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605050033
Hyphenated Format 60505-0033

Supplemental Identifiers

RxCUI
312301
UNII
SD6QCT3TSU
NUI
N0000175895 N0000009065

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pentoxifylline (source: ndc)
Generic Name pentoxifylline (source: ndc)
Application Number ANDA075191 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-6)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-7)
source: ndc

Packages (2)

60505-0033-6 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-6) 60505-0033-7 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-7)

Ingredients (1)

pentoxifylline (400 mg/1)

Linked Drug Pages (1)

PENTOXIFYLLINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e67bdb49-8c37-8b4f-c982-67d024d3f2aa", "openfda": {"nui": ["N0000175895", "N0000009065"], "unii": ["SD6QCT3TSU"], "rxcui": ["312301"], "spl_set_id": ["40ae2d9a-0d95-640d-0640-f76e7e1a13cb"], "pharm_class_pe": ["Hematologic Activity Alteration [PE]"], "pharm_class_epc": ["Blood Viscosity Reducer [EPC]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-6)", "package_ndc": "60505-0033-6", "marketing_start_date": "19990610"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-7)", "package_ndc": "60505-0033-7", "marketing_start_date": "19990610"}], "brand_name": "PENTOXIFYLLINE", "product_id": "60505-0033_e67bdb49-8c37-8b4f-c982-67d024d3f2aa", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Blood Viscosity Reducer [EPC]", "Hematologic Activity Alteration [PE]"], "product_ndc": "60505-0033", "generic_name": "PENTOXIFYLLINE", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PENTOXIFYLLINE", "active_ingredients": [{"name": "PENTOXIFYLLINE", "strength": "400 mg/1"}], "application_number": "ANDA075191", "marketing_category": "ANDA", "marketing_start_date": "19990610", "listing_expiration_date": "20261231"}